Tasplan says goodbye to lifecycle MySuperBY KANIKA SOOD | MONDAY, 11 JAN 2021 12:45PMAfter four years of offering its MySuper option as a lifecycle product, Tasplan plans to switch back to single strategy citing higher costs among the reasons. Related News |
Editor's Choice
arcpoint OCIO scores more mandates, Larapinta Private launches
|Recently launched arcpoint OCIO has won three mandates including securing wealth manager and family office Larapinta Private, a new venture set up by a former Koda Capital partner.
Netwealth expands Morgan Stanley mandate
|Amid expanding its stockbroking and private wealth capabilities, Netwealth has been picked by Morgan Stanley to provide a platform solution to its Australian wealth business.
Super funds to reap returns from $2.2bn biotech exit
|Brandon Capital, a life sciences venture capital firm has exited from its investment in Myricx Bio, following its agreement to be acquired by Novartis for US$1.5 billion ($2.2bn).
Mosaic Private names investment chief
|Mosaic Private, the private credit fund manager backed by Flight Centre Travel Group co-founder Geoff Harris' family office, has named its chief investment officer, joining from Centuria Bass Credit.
Products
Featured Profile

Judith Fiander
CHIEF EXECUTIVE OFFICER
AUSTRALIAN PHILANTHROPIC SERVICES
AUSTRALIAN PHILANTHROPIC SERVICES
When Judith Fiander first walked in the doors of Australian Philanthropic Services her intention was to volunteer for a few months. Fast forward 14 years and she is the chief executive. Eliza Bavin writes.







How could this be in Members best retirement interests - where is the published data - successor fund criteria? Even if it lowers fees and is in the funds own interest it hurts members outcomes. What you are invested in (which investment option option) is far more important to retirement outcomes compared to which fund (MTAA or Tasplan). Should be banned along with the directors who approved it. Hopeless understanding of their role.